| Fulminant myocarditis with combination immune checkpoint blockade DB Johnson, JM Balko, ML Compton, S Chalkias, J Gorham, Y Xu, ... New England Journal of Medicine 375 (18), 1749-1755, 2016 | 1983 | 2016 |
| Natural selection on EPAS1 (HIF2α) associated with low hemoglobin concentration in Tibetan highlanders CM Beall, GL Cavalleri, L Deng, RC Elston, Y Gao, J Knight, C Li, JC Li, ... Proceedings of the National Academy of Sciences 107 (25), 11459-11464, 2010 | 909 | 2010 |
| Targeted next generation sequencing identifies markers of response to PD-1 blockade DB Johnson, GM Frampton, MJ Rioth, E Yusko, Y Xu, X Guo, RC Ennis, ... Cancer immunology research 4 (11), 959-967, 2016 | 471 | 2016 |
| Breast-cancer stromal cells with TP53 mutations and nodal metastases A Patocs, L Zhang, Y Xu, F Weber, T Caldes, GL Mutter, P Platzer, C Eng New England Journal of Medicine 357 (25), 2543-2551, 2007 | 365 | 2007 |
| Trans-ethnic association study of blood pressure determinants in over 750,000 individuals A Giri, JN Hellwege, JM Keaton, J Park, C Qiu, HR Warren, ES Torstenson, ... Nature genetics 51 (1), 51-62, 2019 | 363 | 2019 |
| Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer PJ Mazzone, XF Wang, Y Xu, T Mekhail, MC Beukemann, J Na, ... Journal of Thoracic Oncology 7 (1), 137-142, 2012 | 271 | 2012 |
| A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis DB Johnson, WJ McDonnell, PI Gonzalez-Ericsson, RN Al-Rohil, ... Nature medicine 25 (8), 1243-1250, 2019 | 152 | 2019 |
| Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement DB Johnson, MJ Nixon, Y Wang, DY Wang, E Castellanos, MV Estrada, ... JCI insight 3 (24), 2018 | 138 | 2018 |
| Liver failure is uncommon in adults receiving long‐term parenteral nutrition R Salvino, R Ghanta, DL Seidner, E Mascha, Y Xu, E Steiger Journal of Parenteral and Enteral Nutrition 30 (3), 202-208, 2006 | 115 | 2006 |
| Phase II study of ruxolitinib, a selective JAK1/2 inhibitor, in patients with metastatic triple-negative breast cancer DG Stover, CR Gil Del Alcazar, J Brock, H Guo, B Overmoyer, J Balko, ... NPJ breast cancer 4 (1), 10, 2018 | 113 | 2018 |
| Microenvironmental genomic alterations and clinicopathological behavior in head and neck squamous cell carcinoma F Weber, Y Xu, L Zhang, A Patocs, L Shen, P Platzer, C Eng Jama 297 (2), 187-195, 2007 | 111 | 2007 |
| Phenome-wide scanning identifies multiple diseases and disease severity phenotypes associated with HLA variants JH Karnes, L Bastarache, CM Shaffer, S Gaudieri, Y Xu, AM Glazer, ... Science Translational Medicine 9 (389), eaai8708, 2017 | 98 | 2017 |
| Major differences in the responses of primary human leukocyte subsets to IFN-β AHH van Boxel-Dezaire, JA Zula, Y Xu, RM Ransohoff, JW Jacobberger, ... The Journal of Immunology 185 (10), 5888-5899, 2010 | 79 | 2010 |
| Genome-wide analysis of DNA methylation and gene expression defines molecular characteristics of Crohn’s disease-associated fibrosis T Sadler, JM Bhasin, Y Xu, J Barnholz-Sloan, Y Chen, AH Ting, ... Clinical epigenetics 8, 1-12, 2016 | 73 | 2016 |
| Unique DNA methylome profiles in CpG island methylator phenotype colon cancers Y Xu, B Hu, AJ Choi, B Gopalan, BH Lee, MF Kalady, JM Church, AH Ting Genome research 22 (2), 283-291, 2012 | 55 | 2012 |
| Atherosclerosis Susceptibility Loci Identified from a Strain Intercross of Apolipoprotein E–Deficient Mice via a High-Density Genome Scan JD Smith, JM Bhasin, J Baglione, M Settle, Y Xu, J Barnard Arteriosclerosis, thrombosis, and vascular biology 26 (3), 597-603, 2006 | 54 | 2006 |
| Excessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosis RA Rudick, MRS Rani, Y Xu, JC Lee, J Na, J Shrock, A Josyula, E Fisher, ... PLoS One 6 (5), e19262, 2011 | 52 | 2011 |
| A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data sets C Vlasschaert, T Mack, JB Heimlich, A Niroula, MM Uddin, J Weinstock, ... Blood, The Journal of the American Society of Hematology 141 (18), 2214-2223, 2023 | 50 | 2023 |
| Methylome-wide sequencing detects DNA hypermethylation distinguishing indolent from aggressive prostate cancer JM Bhasin, BH Lee, L Matkin, MG Taylor, B Hu, Y Xu, C Magi-Galluzzi, ... Cell reports 13 (10), 2135-2146, 2015 | 49 | 2015 |
| Targeted next generation sequencing identifies markers of response to PD-1 blockade. Cancer Immunol. Res. 2016; 4: 959–967. doi: 10.1158/2326-6066 DB Johnson, GM Frampton, MJ Rioth, E Yusko, Y Xu, X Guo, RC Ennis, ... CIR-16-0143.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 48 | |
